Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment

BACKGROUND: Patients infected with Hepatitis C virus (HCV) are recommended to receive treatment with direct-acting antiviral agents (DAAs), which have been certified to obtain a high sustained virological response (SVR). However, little is known about the benefits of successful anti-viral treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Bin, Zang, Wenqian, Zhou, Hui, Mi, Yuqiang, Lu, Chengzhen, Li, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069046/
https://www.ncbi.nlm.nih.gov/pubmed/37013471
http://dx.doi.org/10.1186/s12876-023-02732-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069046/
https://www.ncbi.nlm.nih.gov/pubmed/37013471
http://dx.doi.org/10.1186/s12876-023-02732-4

Ejemplares similares